Abstract
Objective
The aim of this study was to investigate early atherosclerotic changes in juvenileonset systemic lupus erythematosus (jSLE) patients and its relation with disease activity.
Patients and methods
Thirty patients suffering from jSLE diagnosed according to the 2012 SLICC SLE criteria were included in the study. Clinical and laboratory parameters, disease activity, and traditional risk factors for atherosclerosis were assessed. B-mode ultrasound was performed to measure carotid intima–media thickness (CIMT) and the number and size of plaque deposits in both the left and the right common carotid arteries. A total of 20 healthy volunteers were taken as a control group.
Results
The mean±SD age of the patients was 18.93±2.81. The mean±SD disease duration was 4.33±2.25. The mean±SD CIMT differed significantly between the patient and control (n=20) groups (0.74±0.21 vs. 0.38±0.05; P<0.001). The presence of lymphopenia, serum creatinine, total cholesterol, triglycerides, and low-density lipoprotein was positively associated with the progression of CIMT (P=0.049, P=0.02, P≤0.001, P≤0.001, and P=0.006, respectively).
Conclusion
In patients with jSLE, some traditional and nontraditional risk factors such as increased low-density lipoprotein, triglycerides, total cholesterol, BMI, fasting blood sugar, and proteinuria for the development of subclinical atherosclerosis were identified. It is likely that good disease control is the optimum way to prevent premature atherosclerosis in jSLE.
Article PDF
Similar content being viewed by others
References
Thomas G, Mancini J, Jourde-Chiche N, Sarlon G, Amoura Z, Harlé JR, et al. Mortality associated with systemic lupus erythematosus in France assessed by multiple-cause-of-death analysis. Arthritis Rheumatol 2014; 66:2503–2511.
Hersh AO, Trupin L, Yazdany J, Panopalis P, Julian L, Katz P, et al. Childhood-onset disease as a predictor of mortality in an adult cohort of patients with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2010; 62:1152–1159.
Sozeri B, Deveei M, Dineel N, Mir S. The early cardiovascular changes in pediatric patients with systemic lupus erythmatosus. Pediatr Nephrol 2012; 28:471–476.
Barsalou J, Bradley TJ, Silverman ED. Cardiovascular risk in pediatriconset rheumatological diseases. Arthritis Res Ther 2013; 15:212.
Urbina EM, Williams RV, Alpert BS, Collins RT, Daniels SR, Hayman L, et al. Noninvasive assessment of subclinical atherosclerosis in children and adolescents: recommendations for standard assessment for clinical research: a scientific statement from the American Heart Association. Hypertension 2009; 54:919–950.
Den Ruijter HM, Peters SA, Anderson TJ, Britton AR, Dekker JM, Eijkemans MJ, et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 2012; 308:796–803.
Anderson TJ, Charbonneau F, Title LM, Buithieu J, Rose MS, Conradson H, et al. Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study. Circulation 2011; 123:163–169.
Vlachopoulos C, Aznaouridis K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis. J Am Coll Cardiol 2010; 55:1318–1327.
Gomez-Marcos MA, Recio-Rodríguez JI, Patino-Alonso MC, Agudo- Conde C, Gomez-Sanchez L, Gomez-Sanchez M, et al. Protocol for measuring carotid intima–media thickness that best correlates with cardiovascular risk and target organ damage. Am J Hypertens 2012; 25:955–961.
George JM, Bhat R, Pai KM, S. A, Jeganathan J. The carotid intima media thickness: a predictor of the clinical coronary events. J Clin Diagn Res: JCDR 2013; 7:1082–1085. doi:10.7860/JCDR/2013/4767.3029.
Petri M, Orbai AM, Alarcón GS, Gordon C, Merrill JT, Fortin PR, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64:2677–2686.
Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 2005; 2009:60.
Stoll T, Sutcliffe N, Mach J, Klaghofer R, Isenberg DA. Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus − a 5-yr prospective study. Rheumatology (Oxford) 2004; 43:1039–1044.
Doria A, Shoenfeld Y, Wu R, Gambari PF, Puato M, Ghirardello A, et al. Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus. Ann Rheum Dis 2003; 62:1071–1077.
Zwiebel W. Normal findings and technical aspects of carotid sonography. In Zwiebel WJ, editor. Introduction vascular sonography. W.B. Saunders Company; 2004. 143–154.
Aggoun Y, Farpour-Lambert NJ, Marchand LM, Golay E, Maggio AB, Beghetti M. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 2008; 29:792–799.
Tyrrell PN, Beyene J, Benseler SM, Sarkissian T, Silverman ED. Predictors of lipid abnormalities in children with new-onset systemic lupus erythematosus. J Rheumatol 2007; 34:2112–2119.
Gasparyan AY, Stavropoulos-Kalinoglou A, Mikhailidis DP, Toms TE, Douglas KM, Kitas GD. The rationale for comparative studies of accelerated atherosclerosis in rheumatic diseases. Curr Vasc Pharmacol 2010; 8:437–449.
Huang YL, Chung HT, Chang CJ, Yeh KW, Chen LC, Huang JL. Lymphopenia is a risk factor in the progression of carotid intima-media thickness in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2009; 60:3766–3775.
Falaschi F, Ravelli A, Martignoni A, Migliavacca D, Sartori M, Pistorio A, et al. Nephrotic-range proteinuria, the major risk factor for early atherosclerosis in juvenile-onset systemic lupus erythematosus. Arthritis Rheum 2000; 43:1405–1409.
Vilá LM, Alarcón GS, McGwin G Jr, Bastian HM, Fessler BJ, Reveille JD, Lumina Study Group. Systemic lupus erythematosus in a multiethnic US cohort, XXXVII: association of lymphopenia with clinical manifestations, serologic abnormalities, disease activity, and damage accrual. Arthritis Rheum 2006; 55:799–806.
O’Rourke MF, Safar ME. Relationship between aortic stiffening and microvascular disease in brain and kidney: cause and logic of therapy. Hypertension 2005; 46:200–204.
Author information
Authors and Affiliations
Corresponding author
Additional information
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.
Rights and permissions
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ahmed, E.A.S., Ganeb, S.S., El-shambaky, A.Y. et al. Study of early atherosclerosis in juvenile-onset systemic lupus erythematosus patients. Egypt Rheumatol Rehabil 44, 11–16 (2017). https://doi.org/10.4103/1110-161X.200835
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.4103/1110-161X.200835